BLOOD RESEARCH

Quick links

Most Cited Most Read Ahead of Print Archives Go to E-submission

Archives

Archives

Volume 59, 2024

REVIEWFebruary 13, 2024

0 1214 187

Genomic technologies for detecting structural variations in hematologic malignancies

Mi‑Ae Jang
Blood Res (2024) 59:1
RESEARCHFebruary 19, 2024

0 878 136

Adding MYC/BCL2 double expression to NCCN-IPI may not improve prognostic value to an acceptable level

Naree Warnnissorn, Nonglak Kanitsap, Pimjai Niparuck, Paisarn Boonsakan, Prapasri Kulalert, Wasithep Limvorapitak, Lantarima Bhoopat, Supawee Saengboon, Chinnawut Suriyonplengsaeng, Pichika Chantrathammachart, Teeraya Puavilai and Suporn Chuncharunee
Blood Res (2024) 59:2
RESEARCHFebruary 19, 2024

0 814 154

Real-world incidence and risk factors of bortezomib-related cardiovascular adverse events in patients with multiple myeloma

Bitna Jang, Jonghyun Jeong, Kyu‑Nam Heo, Youngil Koh and Ju‑Yeun Lee
Blood Res (2024) 59:3
RESEARCHFebruary 19, 2024

0 562 122

Upregulation of lnc-FOXD2-AS1, CDC45, and CDK1 in patients with primary non-M3 AML is associated with a worse prognosis

Saba Manoochehrabadi, Morteza Talebi, Hossein Pashaiefar, Soudeh Ghafouri‑Fard, Mohammad Vaezi, Mir Davood Omrani and Mohammad Ahmadvand
Blood Res (2024) 59:4
IMAGEFebruary 26, 2024

0 469 103

Peripheral T-cell lymphoma, NOS in bone marrow and heart

Hye Won Lee and Ja Young Lee
Blood Res (2024) 59:5
RESEARCHFebruary 26, 2024

0 612 115

Comparable outcomes with low-dose and standard-dose horse anti-thymocyte globulin in the treatment of severe aplastic anemia

Arihant Jain, Aditya Jandial, Thenmozhi Mani, Kamal Kishore, Charanpreet Singh, Deepesh Lad, Gaurav Prakash, Alka Khadwal, Reena Das, Neelam Varma, Subhash Varma and Pankaj Malhotra
Blood Res (2024) 59:6
IMAGEFebruary 28, 2024

0 356 122

Gaucher or pseudo-Gaucher cells

Gurpreet Kaur, Ankur Ahuja, Ganesh Kumar Vishwananthan and Arijit Sen
Blood Res (2024) 59:7
RESEARCHMarch 1, 2024

0 723 140

Cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) gene polymorphisms in a cohort of Egyptian patients with immune thrombocytopenia (ITP)

Doaa Mohamed El Demerdash , Maha Mohamed Saber, Alia Ayad, Kareeman Gomaa and Mohamed Abdelkader Morad
Blood Res (2024) 59:8
RESEARCHMarch 4, 2024

0 742 118

Impact of CYP1A1 variants on the risk of acute lymphoblastic leukemia: evidence from an updated meta-analysis

Imen Frikha, Rim Frikha, Moez Medhaffer, Hanen Charfi, Fatma Turki and Moez Elloumi
Blood Res (2024) 59:9
IMAGEMarch 6, 2024

0 595 108

Acute erythroid leukemia leading to the diagnosis of Schwachman-Diamond syndrome

Bernhard Strasser, Sebastian Mustafa, Josef Tomasits and Alexander Haushofer
Blood Res (2024) 59:10

1
2
3

Blood Res

Volume 59 2024

Current Issue Archives

Archives

2020s
2010s
2000s
1990s
1980s
1970s
1960s

2024
2023
2022
2021
2020

2019
2018
2017
2016
2015
2014
2013
2012
2011
2010

2009
2008
2007
2006
2005
2004
2003
2002
2001
2000

1999
1998
1997
1996
1995
1994
1993
1992
1991
1990

1989
1988
1987
1986
1985
1984
1983
1982
1981
1980

1979
1978
1977
1976
1975
1974
1973
1972
1971
1970

1969
1968
1967
1966

Apr. Vol. 58 No. S1.

Mar. Vol. 58 No. 1. 1~82

Jun. Vol. 58 No. 2. 83~124

Sep. Vol. 58 No. 3. 125~164

Dec. Vol. 58 No. 4. 165~245

Apr. Vol. 57 No. S1.

Mar. Vol. 57 No. 1. 1~84

Jun. Vol. 57 No. 2. 85~171

Sep. Vol. 57 No. 3. 173~246

Dec. Vol. 57 No. 4. 247~297

Apr. Vol. 56 No. S1.

Mar. Vol. 56 No. 1. 1~58

Jun. Vol. 56 No. 2. 59~123

Sep. Vol. 56 No. 3. 125~207

Dec. Vol. 56 No. 4. 209~353

Jul. Vol. 55 No. S1.

Mar. Vol. 55 No. 1. 1~69

Jun. Vol. 55 No. 2. 71~128

Sep. Vol. 55 No. 3. 129~189

Dec. Vol. 55 No. 4. 191~282

Mar. Vol. 54 No. 1. 1~79

Jun. Vol. 54 No. 2. 81~158

Sep. Vol. 54 No. 3. 159~240

Dec. Vol. 54 No. 4. 241~295

Mar. Vol. 53 No. 1. 1~94

Jun. Vol. 53 No. 2. 95~182

Sep. Vol. 53 No. 3. 183~264

Dec. Vol. 53 No. 4. 265~336

Mar. Vol. 52 No. 1. 1~76

Jun. Vol. 52 No. 2. 77~150

Sep. Vol. 52 No. 3. 151~233

Dec. Vol. 52 No. 4. 235~339

Mar. Vol. 51 No. 1. 1~68

Jun. Vol. 51 No. 2. 69~147

Sep. Vol. 51 No. 3. 149~214

Dec. Vol. 51 No. 4. 215~299

Mar. Vol. 50 No. 1. 1~65

Jun. Vol. 50 No. 2. 67~121

Sep. Vol. 50 No. 3. 123~185

Dec. Vol. 50 No. 4. 187~267

Mar. Vol. 49 No. 1. 1~73

Jun. Vol. 49 No. 2. 75~137

Sep. Vol. 49 No. 3. 139~207

Dec. Vol. 49 No. 4. 209~285

Mar. Vol. 48 No. 1. 1~69

Jun. Vol. 48 No. 2. 71~163

Sep. Vol. 48 No. 3. 165~234

Dec. Vol. 48 No. 4. 235~303

Mar. Vol. 47 No. 1. 1~82

Jun. Vol. 47 No. 2. 85~156

Sep. Vol. 47 No. 3. 157~238

Dec. Vol. 47 No. 4. 239~310

Mar. Vol. 46 No. 1. 1~58

Jun. Vol. 46 No. 2. 59~144

Sep. Vol. 46 No. 3. 145~208

Dec. Vol. 46 No. 4. 209~288

Mar. Vol. 45 No. 1. 1~75

Jun. Vol. 45 No. 2. 77~140

Sep. Vol. 45 No. 3. 143~212

Dec. Vol. 45 No. 4. 215~285

Mar. Vol. 44 No. 1. 1~65

Jun. Vol. 44 No. 2. 67~126

Sep. Vol. 44 No. 3. 127~197

Dec. Vol. 44 No. 4. 199~340

Mar. Vol. 43 No. 1. 1~66

Jun. Vol. 43 No. 2. 69~124

Sep. Vol. 43 No. 3. 127~201

Dec. Vol. 43 No. 4. 203~279

Mar. Vol. 42 No. 1. 1~70

Jun. Vol. 42 No. 2. 71~179

Sep. Vol. 42 No. 3. 181~300

Dec. Vol. 42 No. 4. 301~443

Mar. Vol. 41 No. 1. 1~70

Jun. Vol. 41 No. 2. 73~136

Sep. Vol. 41 No. 3. 139~223

Dec. Vol. 41 No. 4. 225~326

Mar. Vol. 40 No. 1. 1~62

Jun. Vol. 40 No. 2. 65~132

Sep. Vol. 40 No. 3. 135~208

Dec. Vol. 40 No. 4. 211~282

Mar. Vol. 39 No. 1. 1~54

Jun. Vol. 39 No. 2. 59~117

Sep. Vol. 39 No. 3. 127~199

Dec. Vol. 39 No. 4. 209~261

Mar. Vol. 38 No. 1. 1~76

Jun. Vol. 38 No. 2. 81~150

Sep. Vol. 38 No. 3. 157~216

Dec. Vol. 38 No. 4. 221~278

Mar. Vol. 37 No. 1. 1~87

Jun. Vol. 37 No. 2. 89~167

Sep. Vol. 37 No. 3. 169~240

Dec. Vol. 37 No. 4. 259~311

Mar. Vol. 36 No. 1. 1~104

Jun. Vol. 36 No. 2. 105~179

Sep. Vol. 36 No. 3. 181~273

Dec. Vol. 36 No. 4. 275~363

Mar. Vol. 35 No. 1. 1~96

Jun. Vol. 35 No. 2. 97~194

Sep. Vol. 35 No. 3. 195~306

Mar. Vol. 34 No. 1. 1~162

Jun. Vol. 34 No. 2. 189~354

Sep. Vol. 34 No. 3. 359~511

Dec. Vol. 34 No. 4. 513~650

Mar. Vol. 33 No. 1. 48~145

Jun. Vol. 33 No. 2. 171~299

Sep. Vol. 33 No. 3. 303~474

Mar. Vol. 32 No. 1. 22~156

Jun. Vol. 32 No. 2. 203~328

Sep. Vol. 32 No. 3. 333~494

Mar. Vol. 31 No. 1. 61~180

Jun. Vol. 31 No. 2. 211~356

Sep. Vol. 31 No. 3. 359~505

Mar. Vol. 30 No. 1. 39~160

Jun. Vol. 30 No. 2. 197~342

Sep. Vol. 30 No. 3. 345~507

Mar. Vol. 29 No. 1. 1~116

Jun. Vol. 29 No. 2. 171~254

Sep. Vol. 29 No. 3. 259~380

Mar. Vol. 28 No. 1. 1~194

Jun. Vol. 28 No. 2. 241~440

Mar. Vol. 27 No. 1. 1~199

Jun. Vol. 27 No. 2. 227~451

Mar. Vol. 26 No. 1. 1~217

Jun. Vol. 26 No. 2. 245~461

Mar. Vol. 25 No. 1. 1~309

Jun. Vol. 25 No. 2. 327~610

Mar. Vol. 24 No. 1. 1~278

Jun. Vol. 24 No. 2. 301~562

Mar. Vol. 23 No. 1. 1~289

Jun. Vol. 23 No. 2. 313~533

Mar. Vol. 22 No. 1. 1~182

Jun. Vol. 22 No. 2. 205~417

Mar. Vol. 21 No. 1. 1~138

Jun. Vol. 21 No. 2. 169~346

Mar. Vol. 20 No. 1. 5~172

Jun. Vol. 20 No. 2. 199~371

Mar. Vol. 19 No. 1. 5~175

Jun. Vol. 19 No. 2. 207~395

Mar. Vol. 18 No. 1. 3~147

Jun. Vol. 18 No. 2. 169~281

Mar. Vol. 17 No. 1. 3~90

Jun. Vol. 17 No. 2. 115~221

Mar. Vol. 16 No. 1. 3~48

Jun. Vol. 16 No. 2. 71~161

Mar. Vol. 15 No. 1. 3~67

Jun. Vol. 15 No. 2. 87~147

Mar. Vol. 14 No. 1. 3~100

Mar. Vol. 13 No. 1. 1~70

Jun. Vol. 13 No. 2. 89~141

Mar. Vol. 12 No. 1. 1~79

Jun. Vol. 12 No. 2. 97~171

Mar. Vol. 11 No. 1. 3~69

Mar. Vol. 10 No. 1. 3~83

Mar. Vol. 9 No. 1. 1~33

Mar. Vol. 8 No. 1. 1~41

Jun. Vol. 8 No. 2. 1~55

Mar. Vol. 7 No. 1. 1~52

Mar. Vol. 6 No. 1. 1~43

Jun. Vol. 6 No. 2. 53~116

Mar. Vol. 5 No. 1. 1~53

Mar. Vol. 4 No. 1. 1~37

Mar. Vol. 3 No. 1. 1~55

Mar. Vol. 2 No. 1. 1~54

Mar. Vol. 1 No. 1. 3~80

pISSN 2287-979X
eISSN 2288-0011

qr-code